［1］Tang Z，Jiang S，Du R，et al.Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity［J］.Oncogene，2009，28(4)：518-533.
［2］Soda M，Choi YL,Enomoto M.Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer［J］.Nature，2007，448(2)：561-566.
［3］Sasaki T，Rodig SJ，Chirieac LR，et al.The biology and treatment of EML4-ALK non-small cell lung cancer［J］.Eur J Cancer，2010，46(10)：1773-1780.
［4］Crystal AS，Shaw AT.New targets in advanced NSCLC：EML4-ALK［J］.Clin Adv Hematol Oncol，2011，9(3)：207-214.
［5］Peters S，Adjei AA，Gridelli C，et al.Metastatic non-small-cell lung cancer(NSCLC)：ESMO Clinical Practice Guidelines for diagnosis，treatment and follow-up［J］.Ann Oncol，2012，23(7)：56-64.
［6］Gridelli C，Peters S，Sgambato A，et al.ALK inhibitors in the treatment of advanced NSCLC［J］.Cancer Treat Rev，2014，40(2)：300-306.
［7］Dacic S，Villaruz LC，Abberbock S，et al.ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma［J］.Oncotarget，2016，7(50)：82943-82952.
［8］Mphil WSW，Leung LH，Wongc KM，et al.A novel KIF5B-ALK，variant in non-small cell lung cancer［J］.Cancer，2011，117(12)：2709-2718.
［9］Wong WS，Leung LH，Wong KM，et al.Abstract 1121：A novel KIF5B-ALK fusion gene variant with transforming potentials in non-small cell lung cancer［J］.Cancer Research，2011，71(8 Supplement)：1121.
［10］Jung Y，Kim P，Jung Y，et al.Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing［J］.Genes Chromosomes & Cancer，2012，51(6)：590-597.
［11］Togashi Y，Soda M，Sakata S，et al.KLC1-ALK：A novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only［J］.Plos One，2012，7(2)：e31323.
［12］Zhang Xingsong，Wei Wanli.Research progress of lung cancer and EML4-ALK fusion gene［J］.Modern Oncology，2014，22(5)：1226-1230.［张邢松，魏万里.肺癌组织中 EML4-ALK 基因表达的研究进展［J］.现代肿瘤医学，2014，22(5)：1226-1230.］
［13］Siegel R，Desantis C，Jemal A.Colorectal cancer statistics［J］.CA Cancer J Clin，2014，64(2)：104-117.
［14］DeSantis CE，Lin CC，Mariotto AB，et al.Cancer treatment and survivorship statistics［J］.CA Cancer J Clin，2014，64(4)：252-271.
［15］Le Shengbing，Wu Milu.Research progress of target therapy in non-small cell lung cancer［J］.Modern Oncology，2016，24(5)：840-843.［乐胜兵，吴密璐.非小细胞肺癌靶向治疗研究进展［J］.现代肿瘤医学，2016，24(5)：840-843.］
［16］Rodney E Shackelford，Moiz Vora，Kim Mayhall，et al.ALK-rearrangements and testing methods in non-small cell lung cancer：a review［J］.Genes & Cancer，2014，5(1-2)：1-14.
［17］Evangelista AF，Zanon MF，Carloni AC，et al.Detection of ALK fusion transcripts in FFPE lung cancer samples by Nanostring technology［J］.Bmc Pulmonary Medicine，2017，17(1)：86.